These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
440 related items for PubMed ID: 15477106
1. HLA-specific antibodies are associated with high-grade and persistent-recurrent lung allograft acute rejection. Girnita AL, McCurry KR, Iacono AT, Duquesnoy R, Corcoran TE, Awad M, Spichty KJ, Yousem SA, Burckart G, Dauber JH, Griffith BP, Zeevi A. J Heart Lung Transplant; 2004 Oct; 23(10):1135-41. PubMed ID: 15477106 [Abstract] [Full Text] [Related]
2. Impact of ELISA-detected anti-HLA antibodies on pediatric cardiac allograft outcome. Di Filippo S, Girnita A, Webber SA, Tsao S, Boyle GJ, Miller SA, Gandhi SK, Zeevi A. Hum Immunol; 2005 May; 66(5):513-8. PubMed ID: 15935888 [Abstract] [Full Text] [Related]
3. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation. Lee PC, Ozawa M. Clin Transpl; 2007 May; ():219-26. PubMed ID: 18642453 [Abstract] [Full Text] [Related]
4. Post transplant development of MICA and anti-HLA antibodies is associated with acute rejection episodes and renal allograft loss. Panigrahi A, Gupta N, Siddiqui JA, Margoob A, Bhowmik D, Guleria S, Mehra NK. Hum Immunol; 2007 May; 68(5):362-7. PubMed ID: 17462503 [Abstract] [Full Text] [Related]
5. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients. Meng HL, Jin XB, Li XT, Wang HW, Lü JJ. Chin Med J (Engl); 2009 Feb 20; 122(4):420-6. PubMed ID: 19302748 [Abstract] [Full Text] [Related]
6. Immunoglobulin M-to-immunoglobulin G anti-human leukocyte antigen class II antibody switching in cardiac transplant recipients is associated with an increased risk of cellular rejection and coronary artery disease. Lietz K, John R, Burke E, Schuster M, Rogers TB, Suciu-Foca N, Mancini D, Itescu S. Circulation; 2005 Oct 18; 112(16):2468-76. PubMed ID: 16230499 [Abstract] [Full Text] [Related]
7. Myocardial HLA-G reliably indicates a low risk of acute cellular rejection in heart transplant recipients. Sheshgiri R, Rouas-Freiss N, Rao V, Butany J, Ramzy D, Krawice-Radanne I, Ross HJ, Carosella ED, Delgado DH. J Heart Lung Transplant; 2008 May 18; 27(5):522-7. PubMed ID: 18442718 [Abstract] [Full Text] [Related]
8. HLA mismatches remain risk factors for acute kidney allograft rejection in patients receiving quadruple immunosuppression with anti-interleukin-2 receptor antibodies. Wissing KM, Fomegné G, Broeders N, Ghisdal L, Hoang AD, Mikhalski D, Donckier V, Vereerstraeten P, Abramowicz D. Transplantation; 2008 Feb 15; 85(3):411-6. PubMed ID: 18322434 [Abstract] [Full Text] [Related]
9. Donor-specific HLA alloantibodies: long-term impact on cardiac allograft vasculopathy and mortality after heart transplant. Kaczmarek I, Deutsch MA, Kauke T, Beiras-Fernandez A, Schmoeckel M, Vicol C, Sodian R, Reichart B, Spannagl M, Ueberfuhr P. Exp Clin Transplant; 2008 Sep 15; 6(3):229-35. PubMed ID: 18954302 [Abstract] [Full Text] [Related]
10. Aortic valve allograft structural deterioration is associated with a subset of antibodies to human leukocyte antigens. Dignan R, O'Brien M, Hogan P, Thornton A, Fowler K, Byrne D, Stephens F, Harrocks S. J Heart Valve Dis; 2003 May 15; 12(3):382-90; discussion 390-1. PubMed ID: 12803340 [Abstract] [Full Text] [Related]
11. Presensitized kidney graft recipients with HLA class I and II antibodies are at increased risk for graft failure: a Collaborative Transplant Study report. Süsal C, Döhler B, Opelz G. Hum Immunol; 2009 Aug 15; 70(8):569-73. PubMed ID: 19375472 [Abstract] [Full Text] [Related]
12. Increased lung allograft failure in patients with HLA-specific antibody. Girnita AL, McCurry KR, Zeevi A. Clin Transpl; 2007 Aug 15; ():231-9. PubMed ID: 18637473 [Abstract] [Full Text] [Related]
16. Soluble CD30 and HLA antibodies as potential risk factors for kidney transplant rejection. Slavcev A, Lácha J, Honsová E, Sajdlová H, Lodererová A, Vitko S, Skibová J, Striz I. Transpl Immunol; 2005 Jun 15; 14(2):117-21. PubMed ID: 15935302 [Abstract] [Full Text] [Related]
17. Hepatocyte growth factor and antibodies to HLA and MICA antigens in heart transplant recipients. Pavlova YA, Malek I, Honsova E, Netuka I, Sochman J, Lodererova A, Kolesar L, Striz I, Skibova J, Slavcev A. Tissue Antigens; 2010 Nov 15; 76(5):380-6. PubMed ID: 20604893 [Abstract] [Full Text] [Related]
18. Donor-specific antibodies against HLA, MICA, and GSTT1 in patients with allograft rejection and C4d deposition in renal biopsies. Alvarez-Márquez A, Aguilera I, Gentil MA, Caro JL, Bernal G, Fernández Alonso J, Acevedo MJ, Cabello V, Wichmann I, Gonzalez-Escribano MF, Núñez-Roldán A. Transplantation; 2009 Jan 15; 87(1):94-9. PubMed ID: 19136897 [Abstract] [Full Text] [Related]
19. [Effects of the HLA antibodies on allograft acute rejection after cadaveric liver transplantation]. Chen W, Chen GH, Lu MQ, Yang Y, Cai CJ, Hou BH, Lin Y, Zhang WD, Xiao LL. Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jun 15; 26(6):774-6. PubMed ID: 16793598 [Abstract] [Full Text] [Related]
20. Human leukocyte antigen sensitization in ventricular assist device recipients: a lesser risk with the DeBakey axial pump. Grinda JM, Bricourt MO, Amrein C, Salvi S, Guillemain R, Francois A, Guibourt P, Deloche A, Fabiani JN. Ann Thorac Surg; 2005 Sep 15; 80(3):945-8. PubMed ID: 16122460 [Abstract] [Full Text] [Related] Page: [Next] [New Search]